Oct 25, 2024 12:00PM
Oct 22, 2024 04:05PM
Oct 22, 2024 04:05PM
Nov 1, 2023 08:05AM
Nov 1, 2023 08:05AM
Apr 21, 2023 08:00AM
Apr 21, 2023 08:00AM Ocuphire Appoints Rick Rodgers as Interim Chief Executive Officer
Dec 6, 2022 06:00AM
Sep 6, 2022 09:00AM
Aug 12, 2022 07:00AM
Aug 3, 2022 08:03AM
Aug 3, 2022 08:00AM
Jul 7, 2022 08:04AM
Jul 7, 2022 08:00AM Ocuphire Announces Late-Breaking Paper for Nyxol for Reversal of Dilation Indication at Annual ASRS Meeting and Five More Presentations at Conferences in July
Jun 29, 2022 09:02AM
Jun 29, 2022 09:00AM
Jun 8, 2022 08:00AM
May 19, 2022 07:01AM
May 19, 2022 07:00AM
May 13, 2022 08:00AM
May 11, 2022 08:00AM Ocuphire Pharma Announces Upcoming Presentations at the Retina World Congress, Clinical Trials at the Summit, and the H.C. Wainwright Global Investment Conference
Apr 28, 2022 07:04AM
Apr 28, 2022 07:00AM
Apr 26, 2022 09:00AM
Apr 19, 2022 08:10AM
Apr 19, 2022 08:00AM
Apr 6, 2022 08:00AM
Mar 29, 2022 07:00AM Ocuphire Pharma (OCUP) Reports Positive Topline Results from MIRA-3 Phase 3 FDA Registration Trial for Nyxol
Mar 29, 2022 07:00AM
Mar 24, 2022 08:00AM
Mar 16, 2022 07:30AM
Mar 10, 2022 09:27AM
Mar 8, 2022 08:00AM
Feb 8, 2022 08:00AM
Jan 31, 2022 06:05AM Ocuphire Pharma (OCUP) to Present Data and Updates on APX3330 and Nyxol
Jan 31, 2022 06:00AM
Jan 25, 2022 07:00AM
Jan 5, 2022 07:00AM
Dec 8, 2021 08:00AM
Nov 24, 2021 06:36AM
Nov 23, 2021 09:00AM
Nov 12, 2021 07:00AM Ocuphire Announces Financial Results for the Third Quarter 2021 and Provides Corporate Update
Nov 1, 2021 09:30AM
Oct 7, 2021 07:00AM
Oct 1, 2021 08:49AM
Sep 27, 2021 07:00AM
Sep 2, 2021 07:00AM
Aug 12, 2021 07:00AM
Aug 6, 2021 07:30AM Ocuphire Pharma Presenting at Two Conferences in August
Jul 22, 2021 08:00AM

1,155,367 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All